Asthma Flashcards

1
Q

Asthma is the most common chronic disease in …

A

childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Asthma

A

chronic inflammatory disorder of the airways

partially or completely reversible with bronchodilators

controllable but not curable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms

A

wheezing; usually only during asthma attacks/episodic

coughing

shortness of breath

tight chest

itchy or sore throat

rapid breathing

symptoms may be worse at night or wake the patient up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prevalence

A

8-10% of population; 1 in 12; 25 million in U.S>

increasing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Inflammatory cells involved in the immunohistopathologic features of asthma

A

Neutrophils (especially in sudden-onset, fatal asthma exacerbations; occupational asthma, and patients who smoke)

Eosinophils

Lymphocytes

Mast cell activation

Epithelial cell injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk Factors

A

Atopy - the body’s predisposition to develop an antibody called immunoglobin E (IgE) in response to exposure to environmental allergens; can be measured in blood; includes allergic rhinitis, asthma, hay fever, and eczema

Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Triggers

A

environmental: dust mites, cockroach, animal dander, pollens
occupational: chemicals, fumes, smoke

cigarette smoke, upper respiratory infection, exercise, stress, post nasal drip, GERD (reflux)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Samter’s Triad

A

aspirin sensitivity

asthma

nasal polyps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exam Findings

A

Vitals: May have elevated BP/ resp rate, decreased O2 sat

HEENT: allergic conjunctivitis, nasal swelling or polyps, throat erythema from PND (all atopy indicators)

LUNG: wheezing or prolonged expiratory phase; but normal if not having flare; wheezing may be absent during severe exacerbations; not moving enough air to even wheeze (‘silent chest’)

Chest inspection - using accessory muscles to breathe (rib/neck muscles show)

Heart: normal

Derm: cyanosis of lips or nails (if very bad)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What will the Arterial Blood Gas show in people with asthma?

A

respiratory alkalosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What will tested sputum samples have in patients with asthma?

A

eosinophils or serum IGE level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pulmonary Function Tests in Asthma Patients

A

typically done pre- and post-bronchodilator to look for reversibility of airflow obstruction

significant reversibility is defined by in increase of 12% or more and 200 mL in FEV1 or FVC after inhaling a short-acting bronchodilator

may be normal if not having an asthma attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bronchial Provocation Testing/Methacholine Challenge

A

done if asthma suspected but PFT not diagnostic.

A negative test has a negative predictive value for asthma of 95%

people whose airways do not narrow after inhaling methacholine are very unlikely to have asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Peak Expiratory Flow (PEF)

A

personal monitoring tool; used at home; gross estimate of GVC; self-measured and recorded; if patient isn’t trying, the results are not accurate – effort dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fractional Exhaled Nitric Oxide (FeNO)

A

during inflammation, higher-than-normal levels of nitric oxide (NO) are released from epithelial cells of the bronchial wall; the concentration of NO in exhaled breath can help identify airway inflammation

usually used to determine if correct dose of anti-inflammatory is given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

• Increased probability that symptoms are due to asthma if:

A

more than one type of symptoms (wheeze, shortness of breath, cough, chest tightness)

symptoms often worse at night or in the early morning

symptoms vary over time and in intensity

symptoms are triggered by viral infections, exercise, allergen exposure, changes in weather, laughter, irritants such as car exhaust fumes, smoke, or strong smells

17
Q

Decreased probability that symptoms are due to asthma if:

A

isolated cough with no other respiratory symptoms

chronic production of sputum

shortness of breath associated with dizziness, light-headedness or peripheral tingling

chest pain

exercise-induced dyspnea with noisy inspiration (stridor)

18
Q

Asthma severity and asthma control include two domains:

A

Current impairment: frequency and intensity of the patient’s symptoms and functional limitations (current or recent)

Risk: likelihood of untoward events (exacerbations, progressive loss of lung function, or medication side effects)

19
Q

Quick Relief or Rescue Treatment

A

Bronchodilators/(short acting beta agonists) SABAs

(albuterol - Ventolin, Pro Air, Proventil; and others) inhaler or nebulizer

Used to relieve or prevent symptoms (prior to exercise) SABAS FOR ALL

20
Q

Long-term Control Treatments

A

Corticosteroids: Inhaled: Many options, used frequently; Systemic: Oral prednisone, limit exposure

Long acting bronchodilators (LABA) - NEVER MONOTHERAPY, most often as combined inhaler

21
Q

Step Treatment System

A

Step 1 (Intermittent) – SABA PRN

Step 2 (Persistent) – Low dose ICS

Step 3 – Low dose ICS + LABA OR Medium dose ICS; consider consultation

Step 4 – Medium dose + LABA; consult with asthma specialist

Step 5 – High dose ICS + LABA

Step 6 – High dose ICS + LABA + Oral Corticosteroid

22
Q

Intermittent Asthma

A

symptoms: less than or equal to 2 days per week

night-time awakenings: less than or equal to 2 days a month

SABA use: less than or equal to 2 days a week

interference with normal activity: none

Lung Function:
FEV1: normal between exacerbations
FEV1 >80%
FEV1/FVC >85%

23
Q

Mild Asthma

A

symptoms: more than 2 days per week

night-time awakenings: 3-4 days a month

SABA use: more than 2 days a week, but not daily

interference with normal activity: minor

Lung Function:
FEV1 >80%
FEV1/FVC >80%

24
Q

Moderate

A

symptoms: daily

night-time awakenings: 1 time per week, but not nightly

SABA use: daily

interference with normal activity: some

Lung Function:
FEV1: 60-80%
FEV1/FVC : 75-80%

25
Q

Severe Asthma

A

symptoms: throughout the day

night-time awakenings: often; seven times per week

SABA use: several times per day

interference with normal activity: extreme

Lung Function:
FEV1 <60%
FEV1/FVC <75%

26
Q

Rules of Two

A

Do you have asthma symptoms or use your bronchodilator more than two times per week?

Do you refill your bronchodilator medication more than two times per year?

Do you have asthma symptoms that awaken you more than two times per month?

Does your peak flow drop more than 20% (2 X 10%) with symptoms?

NO – asthma is under control

YES to one of these questions – your asthma is not controlled

27
Q

Asthma Action Plan

A

guide for patient self-management effort

Includes:
daily management as well as early recognition and actions for exacerbations

medication names (trade or generic)

how much to take and when to take it

how to adjust medications at home as symptoms change

28
Q

When to Refer

A

when treatments are not working – suboptimal response, not meeting goals after 3-6 months

atypical presentation or uncertain diagnosis of asthma

complicating comorbid problems, such as rhinosinusitis, tobacco use, multiple environmental allergies, suspected allergic bronchopulmonary mycosis.

requires high-dose inhaled corticosteroids for control

more than two courses of oral prednisone therapy in the past 12 months

any life-threatening asthma exacerbation or exacerbation requiring hospitalization in the past 12 months

presence of social or psychological issues interfering with asthma management